BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 233 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,193,867 | +0.6% | 874,840 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $6,158,873 | -15.6% | 874,840 | 0.0% | 0.02% | -17.9% |
| Q1 2023 | $7,296,165 | -66.0% | 874,840 | -53.2% | 0.03% | -64.6% |
| Q4 2022 | $21,452,354 | -5.7% | 1,868,672 | +3.5% | 0.08% | -17.7% |
| Q3 2022 | $22,743,000 | +19.1% | 1,805,072 | 0.0% | 0.10% | +24.7% |
| Q2 2022 | $19,097,000 | +33403.5% | 1,805,072 | +36001.4% | 0.08% | – |
| Q3 2015 | $57,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
| ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
| Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
| Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
| TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
| Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
| AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
| Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
| Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |